Eyenovia, Inc. - Common Stock (EYEN)
0.0359
+0.0010 (2.87%)
Eyenovia Inc is a biotechnology company focused on developing innovative ophthalmic therapeutics utilizing its proprietary delivery technology
The company aims to enhance the treatment of various eye conditions through its advanced product pipeline, which includes specialty pharmaceutical formulations designed to improve the efficacy and patient compliance of eye care treatments. Eyenovia’s pioneering approach leverages microdosing technology to deliver medications more precisely and effectively, potentially transforming the landscape of ocular therapeutics and improving outcomes for patients with vision-related ailments.
| Previous Close | 0.0349 |
|---|---|
| Open | 0.0351 |
| Bid | 0.0358 |
| Ask | 0.0359 |
| Day's Range | 0.0350 - 0.0391 |
| 52 Week Range | 0.0318 - 2.570 |
| Volume | 3,185,703 |
| Market Cap | 3.10M |
| PE Ratio (TTM) | -0.0506 |
| EPS (TTM) | -0.7 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 27,293,664 |
